Table 3.

Association of resistin with cardiac biomarkers and fibrosis variables

		Model 1		Model 2
	N	Resistin coefficient per SD (95% CI)	P value	Resistin coefficient per SD (95% CI)	P value
Limited to Exam 3 when BNP and hs‐cTnT were measured
NT‐proBNP (pg/mL)	226	−11.0 (−32.9, 10.9)	0.322	−11.7 (−33.4, 10.0)	0.289
Hs‐cTnT (ng/L)	721	0.49 (−0.13, 1.11)	0.123	0.44 (−0.16, 1.04)	0.154
Limited to Exam 5 when MRI was conducted
Extracellular volume fraction (%)	195	−0.06 (−0.54, 0.42)	0.815	−0.22 (−0.71, 0.28)	0.390
Pre‐contrast T1 time (ms)	399	2.79 (−1.44, 7.02)	0.196	2.04 (−2.30, 6.38)	0.356
12 min post‐contrast T1 Time (ms)	399	−7.03 (−12.06, −1.99)	0.006	−5.89 (−10.94, −0.84)	0.022
25 min post‐contrast T1 Time (ms)	396	−6.65 (−11.67, −1.62)	0.010	−5.70 (−10.71, −0.70)	0.026
		Odds ratio per SD (95% CI)	P value	Odds ratio per SD (95% CI)	p‐value
Myocardial scar assessment	510	0.92 (0.65, 1.31)	0.649	0.91 (0.63, 1.31)	0.614

hs‐cTnT, high‐sensitive cardiac troponin T; NT‐proBNP, amino‐terminal B‐type natriuretic peptide.

Model 1: adjusted for age, gender, education level, and race/ethnicity.

Model 2: Model 1 covariates plus ASCVD risk score.